ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| 1 |
Trade Desk
TTD
|
$142M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$136M |
| 3 |
ProShares Bitcoin Strategy ETF
BITO
|
$93.2M |
| 4 |
CRISPR Therapeutics
CRSP
|
$85.9M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$77.4M |
Top Sells
| 1 |
Coinbase
COIN
|
$349M |
| 2 |
Grayscale Bitcoin Trust
GBTC
|
$108M |
| 3 |
UiPath
PATH
|
$95.8M |
| 4 |
Roku
ROKU
|
$83.5M |
| 5 |
DraftKings
DKNG
|
$81.4M |
Sector Composition
| 1 | Technology | 33.59% |
| 2 | Healthcare | 27.76% |
| 3 | Financials | 11.83% |
| 4 | Communication Services | 11.57% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coinbase
COIN
$78.2B
| $1.5B | 8.85% | 8,599,683 -2,003,881 | -19% | -$349M |
|
|
2
UiPath
PATH
$5.95B
| $1.08B | 6.39% | 43,470,597 -3,855,679 | -8% | -$95.8M |
|
3
Tesla
TSLA
$1.08T
| $945M | 5.59% | 3,802,519 -276,132 | -7% | -$68.6M |
|
|
XYZ
4
Block, Inc.
XYZ
$48.5B
| $920M | 5.44% | 11,887,628 +1,000,514 | +9% | +$77.4M |
|
|
5
Roku
ROKU
$14.2B
| $873M | 5.17% | 9,528,872 -910,941 | -9% | -$83.5M |
|
6
Zoom
ZM
$24.4B
| $788M | 4.67% | 10,964,576 +781,663 | +8% | +$56.2M |
|
7
Roblox
RBLX
$86.4B
| $544M | 3.22% | 11,906,173 -67,708 | -0.6% | -$3.1M |
|
8
Twilio
TWLO
$16.2B
| $541M | 3.2% | 7,130,187 -1,825 | -0% | -$138K |
|
|
9
CRISPR Therapeutics
CRSP
$4.71B
| $534M | 3.16% | 8,536,104 +1,372,986 | +19% | +$85.9M |
|
10
Unity
U
$16.7B
| $498M | 2.95% | 12,189,778 +712,579 | +6% | +$29.1M |
|
11
Shopify
SHOP
$184B
| $468M | 2.77% | 6,010,496 -944,654 | -14% | -$73.6M |
|
12
Teladoc Health
TDOC
$1.37B
| $457M | 2.71% | 21,224,565 +912,692 | +4% | +$19.7M |
|
13
Exact Sciences
EXAS
$8.98B
| $446M | 2.64% | 6,032,893 -248,038 | -4% | -$18.3M |
|
14
Robinhood
HOOD
$92.4B
| $445M | 2.64% | 34,936,204 +2,101,325 | +6% | +$26.8M |
|
|
15
DraftKings
DKNG
$23.8B
| $434M | 2.57% | 12,317,235 -2,310,617 | -16% | -$81.4M |
|
16
Intellia Therapeutics
NTLA
$1.22B
| $348M | 2.06% | 11,412,449 +1,463,820 | +15% | +$44.6M |
|
17
Pacific Biosciences
PACB
$393M
| $338M | 2% | 34,504,273 +4,681,833 | +16% | +$45.9M |
|
18
Ginkgo Bioworks
DNA
$750M
| $336M | 1.99% | 198,606,619 +16,414,434 | +9% | +$27.7M |
|
19
Twist Bioscience
TWST
$1.63B
| $266M | 1.57% | 7,213,257 +427,274 | +6% | +$15.7M |
|
20
PagerDuty
PD
$1.54B
| $264M | 1.56% | 11,413,423 +858,838 | +8% | +$19.9M |
|
21
Beam Therapeutics
BEAM
$1.66B
| $256M | 1.51% | 9,393,889 +609,998 | +7% | +$16.6M |
|
22
10x Genomics
TXG
$1.74B
| $226M | 1.34% | 4,041,287 +1,047,827 | +35% | +$58.6M |
|
23
Veracyte
VCYT
$2.39B
| $211M | 1.25% | 7,655,603 +62,011 | +0.8% | +$1.71M |
|
|
24
Recursion Pharmaceuticals
RXRX
$2.04B
| $204M | 1.21% | 20,654,287 +13,777,689 | +200% | +$136M |
|
25
Palantir
PLTR
$372B
| $188M | 1.11% | 10,937,859 +1,514,232 | +16% | +$26M |
|